: The proposed research is designed to determine if high expression alleles of macrophage inhibitory factor (MIF) are associated with the development of severe malarial anemia, and to characterize the mechanism whereby MIF suppresses erythropoiesis in the setting of malaria. Infection by P. falciparum results in 1-2 million deaths a year, mostly in African children under the age of five. Death occurs from the complications of infection, which include a severe and refractory anemia. Recent attempts to develop a malaria vaccine in primates also have been hampered by severe anemia after vaccination and challenge infection. The pathophysiology of these anemias is unknown. We have discovered that MIF is expressed in high levels in many malaria-infected individuals, suppresses erythroid progenitor development, and antagonizes erythropoietin signaling. MiF's action thus reflects the clinical analysis of many patients with severe malarial anemia. The objective of this application is to identify the pathogenetic basis for high MIF expression and the mechanism by which MIF interferes with the development of erythroid progenitor cells. The central hypothesis is that severe malarial anemia is the result of genetic predisposition to overproduction of MIF coupled with MIF's capacity to suppress erythropoiesis by inducing sustained activation of the ERK-1/2 MAP kinase cascade. We have formulated this hypothesis on the basis of our experimental studies showing first, that MIF is expressed in the blood and bone marrow during malaria infection, second, that there exists a polymorphism within the promoter of the Mifgene that affects its level of expression and third, that MIF inhibits erythroid progenitor development.
The specific aims of the proposed research are: 1) Define the Frequency of Low Expression (5-CATT) and High Expression (6-, 7-, 8-CATT) Mif Alleles in Patients with Severe Malarial Anemia and Appropriate Controls, and Determine if the High Expression Alleles are Associated with Severe Anemia, and 2) Define the Pathways Responsible for the Suppression of Erythropoiesis during Malaria Infection. We expect to establish that there is over-representation of high expression in patients with severe malarial anemia, and to define the intracellular mechanism by which MIF sustains ERK-1/2 activation and interferes with erythropoietin action. These results will be significant because they will provide a more precise understanding of the molecular pathways responsible for severe malarial anemia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI051306-01A2
Application #
6724450
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Program Officer
Wali, Tonu M
Project Start
2004-05-01
Project End
2009-04-30
Budget Start
2004-05-01
Budget End
2005-04-30
Support Year
1
Fiscal Year
2004
Total Cost
$320,250
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Sun, Tiffany; Holowka, Thomas; Song, Yan et al. (2012) A Plasmodium-encoded cytokine suppresses T-cell immunity during malaria. Proc Natl Acad Sci U S A 109:E2117-26
Thuma, Philip E; van Dijk, Janneke; Bucala, Rick et al. (2011) Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia. J Infect Dis 203:211-9
Malu, Diane Tshikudi; Belanger, Benoit; Desautels, Francois et al. (2011) Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice. J Immunol 186:6271-9
Awandare, Gordon A; Martinson, Jeremy J; Were, Tom et al. (2009) MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia. J Infect Dis 200:629-37
Griffith, Jason W; Sun, Tiffany; McIntosh, Michael T et al. (2009) Pure Hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid. J Immunol 183:5208-20
Kamir, Daniela; Zierow, Swen; Leng, Lin et al. (2008) A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses. J Immunol 180:8250-61
Vermeire, Jon J; Cho, Yoonsang; Lolis, Elias et al. (2008) Orthologs of macrophage migration inhibitory factor from parasitic nematodes. Trends Parasitol 24:355-63
McDevitt, Michael A; Xie, Jianlin; Shanmugasundaram, Ganapathy et al. (2006) A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. J Exp Med 203:1185-96
Zhong, Xiao-bo; Leng, Lin; Beitin, Anna et al. (2005) Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies. Nucleic Acids Res 33:e121
McDevitt, Michael A; Xie, Jianlin; Gordeuk, Victor et al. (2004) The anemia of malaria infection: role of inflammatory cytokines. Curr Hematol Rep 3:97-106